BetterLife Pharma net loss more than triples to CAD 2.7 million for six months ended July 31, 2026

BetterLife Pharma reported a CAD 2.09 million net loss for the three months ended July 31, 2026, with loss from operations widening to CAD 1.27 million; wages rose to CAD 766,622, consulting fees to CAD 147,425, cash rose to CAD 973,593 and total liabilities increased to CAD 9.7 million.